Research Grants 9 show all


$891K
2008

$746.6K
2013

$683.2K
2014

$754K
2015

$118.2K
2016

Patents 530show all

  • 90
    C07K - Peptides
  • 89
    A61K - Preparations for medical, dental, or toilet purposes
  • 83
    C12N - Microorganisms or enzymes
  • 55
    Y02A - Technologies for adaptation to climate change
  • 42
    B21D - Working or processing of sheet metal or metal tubes, rods or profiles without essentially removing material
  • 25
    B65G - Transport or storage devices, e.g. conveyors for loading or tipping, shop conveyor systems or pneumatic tube conveyors
  • 22
    B62D - Motor vehicles
  • 15
    Y02E - Reduction of greenhouse gas [ghg] emissions, related to energy generation, transmission or distribution
  • 14
    B08B - Cleaning in general
  • 13
    B23K - Soldering or unsoldering

Clinical Trials 14show all

8Phase 14Phase 22Phase 1/Phase 2

SEC Filings show all


6
D

Contact Information

Windsor, Newfoundland and Lab
Canada

SEC Form D Funding Events

DateOfferedSoldType
2014-10-02$6,265,125$6,000,000Equity
2012-02-24$24,969,925$24,810,408Debt, Other
2011-02-15$16,857,334$16,679,752Debt, Other
2009-05-19$31,000,000$15,000,000Equity
2004-01-20Unknown Unknown Other (Paper Filing)

Key Executives

  • Andrew T. Drechsler
    Executive Officer
  • Alan R. Shaw
    Director, Executive Officer
  • Franklin H. Top, Jr.
    Director
  • David Williams
    Director
  • Seth F. Berkley
    Director
  • Philippe Chambon
    Director
  • Augustine Lawlor
    Director
  • Seth Rudnick
    Director
  • Gregory Weinhoff
    Director
  • Julie Eskay-Eagle
    Director
  • Thomas Hofstaetter
    Executive Officer, Director, Promoter
  • Sam Wu
    Director
  • Wayne Pisano
    Executive Officer, Director
  • Phillippe O. Chambon
    Director
  • Kathleen A. McGowan
    Executive Officer